Targeting Immune Priming LncRNAs (IPLs) with Antisense Oligonucleotides to Treat Inflammatory Diseases

Time: 11:30 am
day: Day One


  • Lemba has developed the MOSAICTM machine learning AI-engine to identify ASO lead candidates
  • Lead ASOs reduced systemic inflammation and decreased mortality in a humanized model of acute inflammation
  • Targeting IPLs reduced inflammation-mediated choroidal neovascularisation in a porcine model of wet age-related macular degeneration (AMD)